Peptron Inc (087010) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Peptron Inc (087010) has a cash flow conversion efficiency ratio of -0.028x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.63 Billion ≈ $-2.46 Million USD) by net assets (₩129.48 Billion ≈ $87.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Peptron Inc for the company's overall valuation and market capitalisation.
Peptron Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Peptron Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Peptron Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Peptron Inc ranked by their cash flow conversion efficiency. Explore 087010 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Zhangjiagang Rural Commercial Bank Co Ltd
SHE:002839
|
0.253x |
|
Semrush Holdings Inc
NYSE:SEMR
|
0.051x |
|
Eco World Develop Group
KLSE:8206
|
0.031x |
|
Ningbo Ocean Shipping Co. Ltd. A
SHG:601022
|
N/A |
|
Asuransi Jiwa Sinarmas Msig PT
JK:LIFE
|
0.023x |
|
Jiangsu Changfa Refrigeration Co Ltd
SHE:002413
|
0.000x |
|
Odontoprev S.A
SA:ODPV3
|
0.005x |
|
Baoding Lucky Innovative Materials Co Ltd
SHE:300446
|
0.007x |
Annual Cash Flow Conversion Efficiency for Peptron Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Peptron Inc from 2014 to 2025. View latest Peptron Inc stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩142.01 Billion ≈ $96.24 Million |
₩-20.59 Billion ≈ $-13.95 Million |
-0.145x | -72.27% |
| 2024-12-31 | ₩151.71 Billion ≈ $102.81 Million |
₩-12.77 Billion ≈ $-8.65 Million |
-0.084x | +72.30% |
| 2023-12-31 | ₩36.13 Billion ≈ $24.48 Million |
₩-10.97 Billion ≈ $-7.44 Million |
-0.304x | -37.64% |
| 2022-12-31 | ₩53.11 Billion ≈ $35.99 Million |
₩-11.72 Billion ≈ $-7.94 Million |
-0.221x | -29.48% |
| 2021-12-31 | ₩62.28 Billion ≈ $42.21 Million |
₩-10.61 Billion ≈ $-7.19 Million |
-0.170x | +2.98% |
| 2020-12-31 | ₩77.13 Billion ≈ $52.27 Million |
₩-13.55 Billion ≈ $-9.18 Million |
-0.176x | +48.60% |
| 2019-12-31 | ₩28.09 Billion ≈ $19.03 Million |
₩-9.60 Billion ≈ $-6.51 Million |
-0.342x | -268.75% |
| 2018-12-31 | ₩45.10 Billion ≈ $30.56 Million |
₩-4.18 Billion ≈ $-2.83 Million |
-0.093x | +19.36% |
| 2017-12-31 | ₩48.95 Billion ≈ $33.17 Million |
₩-5.63 Billion ≈ $-3.81 Million |
-0.115x | -124.03% |
| 2016-12-31 | ₩53.21 Billion ≈ $36.06 Million |
₩-2.73 Billion ≈ $-1.85 Million |
-0.051x | +62.48% |
| 2015-12-31 | ₩17.23 Billion ≈ $11.67 Million |
₩-2.36 Billion ≈ $-1.60 Million |
-0.137x | +65.62% |
| 2014-12-31 | ₩7.18 Billion ≈ $4.87 Million |
₩-2.86 Billion ≈ $-1.94 Million |
-0.398x | -- |
About Peptron Inc
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, … Read more